Facing radioligand therapy for neuroendocrine cancer? You’re not alone. Our patient guide is designed to help you: • know what to expect • feel more prepared • understand possible side effects ✅Free to download in 15 languages: incalliance.org/net-info-pac... #LetsTalkAboutNETs

Think you’ll never see NENs in your GP practice? Think again. #ThinkNENs is here to help: • Free and CME-accredited course • 7 languages: English, Dutch, French, German, Italian, Portuguese and Spanish • 13 additional videos ✅Enroll now: incalliance.org/think-nens/ #LetsTalkAboutNETs

👏Kudos to NET Research Foundation (NETRF) @netrf.org - its #NETWise podcast has passed the milestone of 100,000 downloads. 📱Listen to the latest episode on “Why Is Neuroendocrine Cancer on the Rise?” and find out more: incalliance.org/netwise-podc... #LetsTalkAboutNETs

Some of the symptoms of carcinoid syndrome could be wheezing (bronchospasm) and / or shortness of breath. 👉It can easily mislead HCPs. ✅Get informed in 13 languages: incalliance.org/net-info-pac... #LetsTalkAboutNETs

For NEN patients it is important to learn about clinical trial experiences from other patients. 📱Watch videos with advice from Marie-Therese from the Netherlands, Cecilia from Mexico, Craig from UK and Anne from Australia: incalliance.org/patient-insi... #LetsTalkAboutNETs

📌INCA welcomes new Board members for term 2026-2028 after elections at the INCA Annual General Meeting 2026: Find out more: incalliance.org/inca-agm-2026/ #LetsTalkAboutNETs

The #ThinkNENs program helps #PrimaryCarePhysicians learn how to identify neuroendocrine neoplasms—quickly and effectively. • Free and self-paced videos • CME-accredited module of 60 mins • 7 languages ✅Start learning today: incalliance.org/think-nens/ #LetsTalkAboutNETs

5% of patients who experience carcinoid syndrome do not have metastases. Diarrhea multiple times a day is a common symptom. It can easily mislead HCPs to think of gastric disease. ✅We help HCPs to know carcinoid syndrome in 12 languages: incalliance.org/net-info-pac... #LetsTalkAboutNETs

📢Listen to the voices of NEN patients! 📌Shuyuan Chen from Taiwan got her NET diagnosis when going to a scheduled colonoscopy as part of a regular health check-up. 📱Watch and read Shuyuan’s story: incalliance.org/stories/shuy... #LetsTalkAboutNETs

📢Today is #WorldHealthDay! The global NEN patient community honors all HCPs who support NEN patients through diagnosis, treatment and care. 👏Thank you for your dedication! ✅Let’s help more HCPs to think NENs – download #NETInfo in your language: incalliance.org/net-info-pac... #LetsTalkAboutNETs

👏Thank you to Samantha Nier, Acute Leukemia Advocates Network (ALAN) Network Director and EHA Patient Advocacy Committee Chair for the video with practical guide on how to plan and prepare for writing articles for medical journals: incalliance.org/advocacy-ski... #LetsTalkAboutNETs

👏Representatives from the Swedish (CarpaNET), Danish (Netpa) and Norwegian (CarciNor) NET patient organizations held a productive Nordic NET meeting to exchange experience and insights. ✅Read more: incalliance.org/nordic-net-m... #LetsTalkAboutNETs

#RadioligandTherapy can feel overwhelming if you don’t know what to expect. There is a special NEN patient guide to help you prepare. 👉Available in 15 languages ✅Download for free: incalliance.org/net-info-pac... #LetsTalkAboutNETs

Just 60 minutes can change how you recognize neuroendocrine cancer. Enroll in #ThinkNENs for free: • CME-accredited • Online, self-paced • 7 languages • Endorsed by leading NEN societies ✅Start the free CME today: incalliance.org/think-nens/ #LetsTalkAboutNETs

Carcinoid syndrome occurs due to an excess production of hormones and peptides from NENs –serotonin, histamine and kinins. 👉One symptom is ‘dry’ flushing: a red ‘blush’ of the face, neck and chest. ✅Get informed in 12 languages: incalliance.org/net-info-pac... #LetsTalkAboutNETs

📢Today is #WorldRadiotheranosticsDay! Let’s spread awareness about the impact of a field that combines therapy and diagnostics to revolutionize cancer treatment. ✅Download INCA’s free patient guide on #RadioligandTherapy, in 15 languages: incalliance.org/net-info-pac... #LetsTalkAboutNETs

📢#WorldRadiotheranosticsDay is on March 31st. #RadioligandTherapy plays a crucial role in NEN treatment and maintaining quality of life during the patient journey. ✅INCA has developed a free patient guide on #RadioligandTherapy in 15 languages: incalliance.org/net-info-pac... #LetsTalkAboutNETs

📌NEW: Now you can use INCA’s new information resource on nutrition in NENs. ✅Explore information from all INCA members worldwide in your language: incalliance.org/nutrition-in... #LetsTalkAboutNETs

👏Kudos to AMEND amenduk.bsky.social for launching a brand-new digital resource for registered members of the charity with #MultipleEndocrineNeoplasia type 1 (MEN1). ✅Find out more: incalliance.org/men1-patient... #LetsTalkAboutNETs

👏Congrats to NeuroEndocrine Cancer Australia for the newly refreshed website! Explore the modern design, improved navigation, and enhanced accessibility. ✅Find out more: incalliance.org/newly-refres... #LetsTalkAboutNETs

When NENs present in primary care, awareness makes all the difference. The #ThinkNENs Global Educational Program supports PCPs in recognizing neuroendocrine cancer earlier. ✔ Free CME ✔ 60-minute module ✔ 13 expert videos ✔ 7 languages Start today: incalliance.org/think-nens/ #LetsTalkAboutNETs

High-grade NENs are aggressive and early diagnosis is vital to receiving timely treatment. ✅We support clinicians to better understand high-grade NENs with #NETInfo factsheets on 26 types of NENs and related syndromes – available in 12 languages: incalliance.org/net-info-pac... #LetsTalkAboutNETs

📌Dr. Justin Annes: “Classical immunotherapies are not likely to be effective with pheo & para – the immune system has a hard time in recognizing these tumors.” 📱Watch the insightful video on #pheo and #para: incalliance.org/dr-justin-an... #LetsTalkAboutNETs

📢March is the European Colorectal Cancer Awareness Month. 👉Let’s put the spotlight on neuroendocrine cancer of the colon. ✅We empower HCPs with #NETInfo factsheet with а comprehensive snapshot of NEN of the colon in 12 languages: incalliance.org/net-info-pac... #LetsTalkAboutNETs #ECCAM2026

Patient advocacy needs to be evidence-based. 📱Watch a video presentation guide on how to collect and analyze data and how to get published in scientific journals: incalliance.org/advocacy-ski... 👏Thank you to Prof. John Ramage for supporting patient advocates! #LetsTalkAboutNETs

👏Kudos to Neuroendocrine Cancer UK @neuroendo-can-uk.bsky.social : The new report on Invisible Cancer had widespread media coverage across the UK, highlighting the urgent challenges facing people with neuroendocrine cancer. ✅Read the report: incalliance.org/ncuk-the-inv... #LetsTalkAboutNETs

📌Para pacientes hispanohablantes: Un podcast médico de NANETS @nanets.bsky.social sobre el manejo del feocromocitoma y paraganglioma. ✅Escuche el podcast aquí: nanets.net/education/ne... #LetsTalkAboutNETs #tumoresneuroendocrinos

Designed for busy primary care physicians. The #ThinkNENs program delivers expert education on neuroendocrine neoplasms in short, practical videos—free, CME-accredited, and globally accessible. • 7 languages Start the free CME today: incalliance.org/think-nens/ #LetsTalkAboutNETs

📢NEW: Check out INCA’s new information resource on nutrition in NENs. 📌This new global resource makes it easy for NEN patients from around the world to find advice on nutrition in their language. ✅Check it out here: incalliance.org/nutrition-in... #LetsTalkAboutNETs

There is a risk of hypercalcemia and neutropenic sepsis with high-grade NENs. Less than 10% of high-grade NECs will have symptoms of a NEN-associated syndrome e.g. carcinoid syndrome. ✅Download a #NETInfo on high-grade NENs in 12 languages: incalliance.org/net-info-pac... #LetsTalkAboutNETs

📢Listen to the voices of the NEN patients! 📌Allison from Australia took part in the routine bowel cancer screening program and that colonoscopy turned out to be life-saving. 📱Watch and read Allison’s story: incalliance.org/stories/alli... #LetsTalkAboutNETs

Learn from NEN patients what it feels like to be participating in a NEN clinical trial. 📌Hear advice from Marie-Therese from the Netherlands, Cecilia from Mexico, Craig from UK and Anne from Australia: incalliance.org/patient-insi... #LetsTalkAboutNETs

👏Kudos to Net Italy ETS for partnering with Sant’Andrea University Hospital in Rome in an innovative event on NENs. Experts and patients discussed diagnosis and personalized therapies. ✅Find out more in English and Italian: incalliance.org/net-italy-ro... #LetsTalkAboutNETs

📌ENETS-INCA educational webinars gather NEN experts, NEN nurses and NEN patient advocates to provide valuable information on NEN patient journey in a patient-friendly language. 📱Watch all videos here: incalliance.org/net-educatio... #LetsTalkAboutNETs

Neuroendocrine neoplasms (NENs) are often misdiagnosed. We call on #PrimaryCarePhysicians to learn to detect them early. Join the FREE Think NENs 60-min course • CME-accredited • 7 languages • Endorsed by leading NEN societies ✅Start learning today: incalliance.org/think-nens/ #LetsTalkAboutNETs

High-grade NENs are represented by NET Grade 3 (Ki67 is above 20%,the cells are well-differentiated) and NEC Grade (Ki67 is above 20%, the cells are poorly-differentiated). Early diagnosis is crucial. ✅We help HCPs to know NENs in 12 languages: incalliance.org/net-info-pac... #LetsTalkAboutNETs

NEN patient advocates can prevent burnout with self-care strategies. 📱Watch a video with structured advice and practical strategies from Amanda Stork, Specialist NET Counsellor, NeuroEndocrine Cancer Australia: incalliance.org/self-care/ #LetsTalkAboutNETs

📢Listen to the voices of the NEN patients! 📌Leslie from USA went through genetic testing as part of her breast cancer journey - early paraganglioma diagnosis helped for timely treatment. ✅Watch Leslie’s story: incalliance.org/stories/lesl... #LetsTalkAboutNETs

📌AI contributes to efficiency in NEN research and clinical care but responsible use is needed – this was the overall conclusion at the INCA-ENETS Symposium 2026 on March 5th. ✅Read the news report on the INCA-ENETS session: incalliance.org/inca-enets-s... #LetsTalkAboutNETs #ENETS2026

📌Here is a new resource helping NEN patients prepare for clinical trials: ✅Check out the questions you should ask while considering a clinical trial: incalliance.org/support-pati... ✅Find a NEN clinical trial: incalliance.org/find-a-trial/ #LetsTalkAboutNETs

📢Don’t miss the new webinar from NCF: Novel Targeted Therapies in Neuroendocrine Cancers on March 9th, 2026, from 8:30 am Pacific. ✅Read more and register: incalliance.org/novel-target... #LetsTalkAboutNETs

Primary care professionals play a critical role in the early diagnosis of NENs. #ThinkNENs Program is here to help – and it's completely FREE. ✔ 60-minute CME-accredited module ✔ 7 languages ✔ Endorsed by leading NEN societies Explore here: incalliance.org/think-nens/ #LetsTalkAboutNETs

📌An opportunity to enhance your advocacy skills for making successful NEN awareness campaigns! 📱Watch a video on “Keys to Media Outreach & Advocacy” with best practice sharing from NeuroEndocrine Cancer Australia: incalliance.org/advocacy-ski... #LetsTalkAboutNETs

👍Here we are at #ENETS2026 - meet us at INCA information booth at the ground floor of ICE Congress Centre! 📌Join @enets.org and INCA for the special session on AI and NEN care on March 5th:https://incalliance.org/inca-enets-symposium-2026/ #LetsTalkAboutNETs

📢2 days away: On March 5th, 2025, from 16:45 CET, in Krakow, INCA and ENETS @enets.org will discuss a very intriguing topic – the role of AI in NEN research and patient care. ✅Look at the agenda: incalliance.org/inca-enets-s... #LetsTalkAboutNETs

High-grade NETs with a Ki-67 index of more than 20% are classified as grade 3. Poorly differentiated Grade 3 tumors are NECs. These tumors are aggressive and are treated differently than lower-grade NETs. 📌We help HCPs know NENs in 12 languages: incalliance.org/net-info-pac... #LetsTalkAboutNETs

📌Today is #RareDiseaseDay! NENs are more common than you think. The prevalence is up at around about 30 or 30+ per 100 000 population. In the UK, for example, around 6,000 people are diagnosed with NENs every year. ✅We help HCPs to be aware: incalliance.org/net-info-pac... #LetsTalkAboutNETs

📢COMING SOON: On March 5th, 2025, from 16:45 CET, in Krakow, INCA and ENETS @enets.org will discuss a very intriguing topic – the role of AI in NEN research and patient care. ✅Look at the agenda: incalliance.org/inca-enets-s... #LetsTalkAboutNETs

👏Kudos to AMEND @amenduk.bsky.social for advocacy in action – a big step towards early detection of genetic NETs. 👉AMEND has helped that MEN2B, will be added to the Genomics England’s Generation Study from March 2026. ✅Find out more: incalliance.org/men2b-added-... #LetsTalkAboutNETs

📢Stay ahead in #PrimaryCare: Free CME credit. Try #ThinkNENs – designed for busy GPs. • FREE online learning in just 60 minutes • Available in 7 languages • Endorsed by leading NEN medical societies • 13 videos on specific NENs ✅Start learning today: incalliance.org/think-nens/ #LetsTalkAboutNETs